Transcenta Holding Limited

HKEX:6628.HK

1.04 (HKD) • At close September 20, 2024
Bedrijfsnaam Transcenta Holding Limited
Symbool 6628.HK
Munteenheid HKD
Prijs 1.04
Beurswaarde 456,648,481
Dividendpercentage 0%
52-weken bereik 0.93 - 4.08
Industrie Biotechnology
Sector Healthcare
CEO Dr. Xueming Qian Ph.D.
Website https://www.transcenta.com

An error occurred while fetching data.

Over Transcenta Holding Limited

Transcenta Holding Limited, a clinical stage biopharmaceutical company, engages in the discovery, research, development, manufacture, and commercialization of various drugs in the People's Republic of China and the United States. The company develops MSB2311, a humanized PD-L1 monoclonal antibody (mAb) candidate for TMB-H solid tumors; TST001, a humanized claudin 18.2

Vergelijkbare Aandelen

SinoMab BioScience Limited logo

SinoMab BioScience Limited

3681.HK

1.23 HKD

EuroEyes International Eye Clinic Limited logo

EuroEyes International Eye Clinic Limited

1846.HK

4.65 HKD

Chaoju Eye Care Holdings Limited logo

Chaoju Eye Care Holdings Limited

2219.HK

2.76 HKD

Shanghai Kindly Medical Instruments Co., Ltd. logo

Shanghai Kindly Medical Instruments Co., Ltd.

1501.HK

28.9 HKD

Essex Bio-Technology Limited logo

Essex Bio-Technology Limited

1061.HK

2.26 HKD

Yestar Healthcare Holdings Company Limited logo

Yestar Healthcare Holdings Company Limited

2393.HK

0.051 HKD

Zhaoke Ophthalmology Limited logo

Zhaoke Ophthalmology Limited

6622.HK

1.37 HKD

Kindstar Globalgene Technology, Inc. logo

Kindstar Globalgene Technology, Inc.

9960.HK

1.22 HKD

Shanghai Conant Optical Co., Ltd. logo

Shanghai Conant Optical Co., Ltd.

2276.HK

14.44 HKD

TOT BIOPHARM International Company Limited logo

TOT BIOPHARM International Company Limited

1875.HK

2 HKD

Financiële Gegevens

Cijfers zijn in miljoenen (HKD)

Cijfers zijn in miljoenen (HKD)